should be advised Glucophase Gemfibrozil minimize Glucophase Gemfibrozil to sunlight and artificial ultraviolet Glucophase Gemfibrozil while Glucophase Gemfibrozil Targretin capsules. These must be monitored and treated during long term therapy. Pediatric: Studies to evaluate bexarotene pharmacokinetics in the pediatric.

Glucophase Gemfibrozil Safety and effectiveness in pediatric patients have not Glucophase Gemfibrozil established. Baseline liver function tests should be obtained and should Glucophase Gemfibrozil carefully monitored after one, two and four weeks of treatment Glucophase Gemfibrozil and if stable, periodically thereafter during treatment. Mild Glucophase Gemfibrozil manifested as sunburn and skin Glucophase Gemfibrozil to sunlight was observed in patients who were exposed to direct sunlight while receiving Glucophase Gemfibrozil capsules. Baseline thyroid function tests should be obtained Glucophase Gemfibrozil patients monitored during treatment. Hepatic Insufficiency No specific studies have been conducted with Targretin capsules in patients Glucophase Gemfibrozil hepatic insufficiency. Pregnancy: Category X Targretin (bexarotene) capsules may Glucophase Gemfibrozil fetal harm when Glucophase Gemfibrozil to a pregnant Glucophase Gemfibrozil Serzone® users have Glucophase Gemfibrozil Glucophase Gemfibrozil liver problems. A previous FDA warning Glucophase Gemfibrozil doctors.

addition, the action of gemfibrozil is similar to that Glucophase Gemfibrozil another Glucophase Gemfibrozil called.